Chlamydia Treatment and Gonorrhoea Treatment are highly prevalent curable sexually transmitted infections (STIs) that are associated with significant adverse reproductive health sequelae among men and women. Within the UK, men who have sex with men constitute a group at high risk of catching Chlamydia and Gonorrhoea infections. Both infections can infect the throat area and as such act as an important reservoir for further transmission to genital sites. Infection rates for men who have sex with men for the throat region range from 1% to 2^% for Chlamydia and 3% to 9% for Gonorrhoea.
Comparing self-collected swabs for the detection of Chlamydia & Gonorrhoea versus clinician collected swabs
The most modern form of Chlamydia & Gonorrhoea Test process are the nucleic acid amplification tests for Chlamydia and Gonorrhoea detection which exhibit high sensitivity compared to culture or enzyme immunoassay tests for diagnosis at genital sites.
The development and availability of self-collection methods has enabled better access to sexual health services in nonclinical settings. This includes Internet based testing programmes and home sampling. Self sampling for STI detection among women using vaginal swabs and men using rectal swabs has been found to be both feasible and efficient.
Various self-sampling methods , including self-collected vaginal and rectal swabs and patient-collected urine specimens, have improved access to Sexual Health Testing services among hard to reach populations.